Patterns of Occurrence and Outcomes of Contralateral Breast Cancer: Analysis of SEER Data

Abstract

Population-based estimates are lacking for the temporal trends in the contralateral breast cancer (CBC) risk for patients with breast cancer (BC). Data for BC patients diagnosed with CBC were collected from the Surveillance, Epidemiology, and End Results database. CBC incidence was calculated using the Kaplan-Meier method and the temporal trend in CBC incidence was assessed using joinpoint regression. Survival analysis was calculated using propensity scoring (PS) and multivariate Cox regression with a competing risk model. We found that 10,944 of 212,630 patients with early-stage BC were subsequently diagnosed with secondary BC in the contralateral breast. The 5-, 10-, 15-, and 20-year cumulative CBC incidences were 1.9, 4.6, 7.6, and 10.5%, respectively. Being younger (<40 years), black, hormone receptor-negative, and having undergone radiotherapy were correlated with a high risk of CBC occurrence. CBC incidence increased continuously in the first 11 years after the initial cancer diagnosis, and the upward trend slowed from years 11 to 21, and tended to decline from years 21 to 24. CBC diagnosis was significantly and negatively associated with survival. We reported population-based estimates of the CBC occurrence pattern and risk factors. Patients are at high risk of developing CBC in the first 21 years after the initial BC diagnosis.

Identification of a 4‐mRNA metastasis‐related prognostic signature for patients with breast cancer

“…Breast cancer (BC) has become a main health burden owing to the high rates of morbidity and cancer‐related mortality among women . Currently, comprehensive treatment strategy for BC, such as chemotherapy, radiotherapy and target therapy, mainly depends on the tumour stage and molecular subtypes .…”

Breast Cancer Estimate Modeling via PDE Thermal Analysis Algorithms

“…This study aimed to predict the location and size of the breast cancer according to the breast surface temperature. If the defect and material data are scaled up as in the above results, then in the future this model could be applied to various different fields [18,19,20].…”

Role of Preoperative MRI in the Management of Newly Diagnosed Breast Cancer Patients

“…This inherent risk of a second primary breast cancer is higher among women who have hereditary susceptibility and the absolute risk over the patient's lifetime will be higher in women who are younger at first breast cancer diagnosis. 17 The lifetime risk might be expected to increase as improved treatments render more patients effectively "cured" of their first cancer, thereby leaving them with a prolonged longevity for a new malignancy to develop in the contralateral breast. Counterbalancing this evolving contralateral risk, however, is the fact that systemic breast cancer treatments also possess antiproliferative chemoprevention benefits, especially with regard to endocrine therapy.…”